|
DE2034118A1
(en)
|
1970-07-09 |
1972-01-13 |
Seinfeld, Hugo, Brendel, Walter, Prof Dr . 8000 München |
Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins
|
|
US5374426A
(en)
|
1986-09-03 |
1994-12-20 |
University Of Saskatchewan |
Rotavirus nucleocapsid protein VP6 in vaccine compositions
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
GB8913737D0
(en)
|
1989-06-15 |
1989-08-02 |
Univ Birmingham |
A novel anti-allergy treatment
|
|
US5039813A
(en)
|
1990-06-29 |
1991-08-13 |
Polaroid Corporation |
2-(4-alkenylphenyl)-5-oxazolones and polymers thereof
|
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
|
WO1992011291A1
(en)
|
1990-12-20 |
1992-07-09 |
Smithkline Beecham Biologicals (S.A.) |
Vaccines based on hepatitis b surface antigen
|
|
GB9101550D0
(en)
|
1991-01-24 |
1991-03-06 |
Mastico Robert A |
Antigen-presenting chimaeric protein
|
|
GB9114003D0
(en)
|
1991-06-28 |
1991-08-14 |
Mastico Robert A |
Chimaeric protein
|
|
GB9213601D0
(en)
|
1992-06-26 |
1992-08-12 |
Mastico Robert A |
Protein based delivery system
|
|
AU678769B2
(en)
|
1992-07-27 |
1997-06-12 |
Hybridon, Inc. |
Oligonucleotide alkylphosphonothioates
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
WO1996002555A1
(en)
|
1994-07-15 |
1996-02-01 |
The University Of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US5935821A
(en)
|
1995-01-17 |
1999-08-10 |
Board Of Trustees Of The University Of Kentucky |
Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
|
WO1996030523A2
(en)
|
1995-03-31 |
1996-10-03 |
Hans Wolf |
Antigen presentation system based on retrovirus-like particles
|
|
US5994315A
(en)
|
1995-06-07 |
1999-11-30 |
East Carolina University |
Low adenosine agent, composition, kit and method for treatment of airway disease
|
|
PT879056E
(pt)
|
1996-01-23 |
2002-10-31 |
Ribapharm Inc |
Modulacao da expressao das citocinas th1/th2 atraves de ribavirina em linfocitos t activados
|
|
WO1997026893A1
(en)
|
1996-01-24 |
1997-07-31 |
Aliatros Medical, A.S. |
Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid
|
|
CA2244946C
(en)
|
1996-01-30 |
2010-04-13 |
The Regents Of The University Of California |
Gene expression vectors which generate an antigen specific immune response and methods of using the same
|
|
GB9621091D0
(en)
|
1996-10-09 |
1996-11-27 |
Fondation Pour Le Perfectionem |
Attenuated microorganisms strains and their uses
|
|
JP4111403B2
(ja)
|
1996-10-11 |
2008-07-02 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
免疫刺激ポリヌクレオチド／免疫調節分子複合体
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
GB9702021D0
(en)
|
1997-01-31 |
1997-03-19 |
Imperial College |
Medicaments
|
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
WO1998049195A1
(en)
|
1997-04-29 |
1998-11-05 |
Universiteit Utrecht |
Corona virus-like particles as tools for vaccination and therapy
|
|
WO1998050071A1
(en)
|
1997-05-01 |
1998-11-12 |
Chiron Corporation |
Use of virus-like particles as adjuvants
|
|
AU7690898A
(en)
|
1997-05-20 |
1998-12-11 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
|
WO1998055495A2
(en)
|
1997-06-06 |
1998-12-10 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
NZ501752A
(en)
|
1997-06-23 |
2000-12-22 |
Ludwig Inst Cancer Res |
Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
|
|
DE19731784A1
(de)
|
1997-07-24 |
1999-02-04 |
Bayer Ag |
Substituierte N-Aryl-N-thioxocarbonyl-sulfonamide
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
DK1009413T3
(da)
|
1997-09-05 |
2007-06-11 |
Univ California |
Anvendelse af immunstimulerende oligonukleotider til forebyggelse eller behandling af astma
|
|
US6171591B1
(en)
|
1997-12-08 |
2001-01-09 |
Pentamer Pharmaceuticals, Inc. |
Recombinant nodavirus compositions and methods
|
|
US6218371B1
(en)
|
1998-04-03 |
2001-04-17 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
|
US5990085A
(en)
|
1998-05-04 |
1999-11-23 |
Michigan State University |
Inhibin-HBc fusion protein
|
|
WO1999058118A2
(en)
|
1998-05-14 |
1999-11-18 |
Cpg Immunopharmaceuticals Gmbh |
METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES
|
|
US7157092B1
(en)
|
1998-06-30 |
2007-01-02 |
Om Pharma |
Acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
|
|
WO2000006588A1
(en)
|
1998-07-27 |
2000-02-10 |
University Of Iowa Research Foundation |
STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
|
|
US5962636A
(en)
|
1998-08-12 |
1999-10-05 |
Amgen Canada Inc. |
Peptides capable of modulating inflammatory heart disease
|
|
EP1108017A2
(en)
|
1998-09-03 |
2001-06-20 |
Coley Pharmaceutical GmbH |
G-motif oligonucleotides and uses thereof
|
|
ATE314095T1
(de)
|
1998-10-21 |
2006-01-15 |
Us Health |
Virusähnliche partikel zur induktion von autoantikörpern
|
|
PL192016B1
(pl)
|
1998-11-30 |
2006-08-31 |
Cytos Biotechnology Ag |
Kompozycja, sposób wytwarzania sztucznego, uporządkowanego i powtarzalnego układu antygenu, zastosowanie kompozycji oraz kompozycja szczepionki
|
|
MXPA01006491A
(es)
|
1998-12-23 |
2003-06-06 |
Thompson Boyce Plant Res |
Expresion de antigenos de superficie de hepatitis b inmunogenicos en plantas transgenicas.
|
|
WO2000039304A2
(en)
|
1998-12-31 |
2000-07-06 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
|
WO2000046365A1
(en)
|
1999-02-02 |
2000-08-10 |
Biocache Pharmaceuticals, Inc. |
Advanced antigen presentation platform
|
|
WO2000050461A1
(en)
|
1999-02-25 |
2000-08-31 |
Smithkline Beecham Biologicals S.A. |
Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
|
|
EP2286792A1
(en)
|
1999-02-26 |
2011-02-23 |
Novartis Vaccines and Diagnostics, Inc. |
Microemulsions with an adsorbent surface, comprising a microdroplet emulsion
|
|
WO2000054803A2
(en)
|
1999-03-16 |
2000-09-21 |
Panacea Pharmaceuticals, Llc |
Immunostimulatory nucleic acids and antigens
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
CN1227030C
(zh)
|
1999-04-19 |
2005-11-16 |
史密丝克莱恩比彻姆生物有限公司 |
包含皂甙和免疫刺激寡核苷酸的佐剂组合物
|
|
WO2001000232A2
(en)
|
1999-06-29 |
2001-01-04 |
Smithkline Beecham Biologicals S.A. |
Use of cpg as an adjuvant for hiv vaccine
|
|
US7479285B1
(en)
|
1999-08-19 |
2009-01-20 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
|
AU6801800A
(en)
|
1999-08-30 |
2001-03-26 |
Ludwig Institute For Cancer Research |
Isolated nona and decapeptides which bind to hla molecules, and the use thereof
|
|
JP2001151698A
(ja)
|
1999-09-10 |
2001-06-05 |
Nichiko Pharmaceutical Co Ltd |
インフルエンザワクチン
|
|
IL148843A0
(en)
|
1999-09-25 |
2002-09-12 |
Univ Iowa Res Found |
Immunostimulatory nucleic acids
|
|
NZ517928A
(en)
|
1999-09-27 |
2004-09-24 |
Coley Pharm Gmbh |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
EP1221968B1
(en)
|
1999-10-13 |
2010-01-13 |
Novartis Vaccines and Diagnostics, Inc. |
Method of obtaining cellular immune responses from proteins
|
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
|
DE60018601D1
(de)
|
1999-11-24 |
2005-04-14 |
Chiron Corp |
HBV/HCV Virus-ohnliche Particle
|
|
US20010044416A1
(en)
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
AU2001236621B2
(en)
|
2000-02-01 |
2006-06-15 |
Mycenax Biotech Inc. |
Cd40-binding apc-activating molecules
|
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
US6756044B1
(en)
|
2000-02-09 |
2004-06-29 |
Genvec, Inc. |
Antigenic complexes and methods
|
|
AU2001239873A1
(en)
|
2000-02-24 |
2001-09-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adjuvant treatment by in vivo activation of dendritic cells
|
|
WO2001085208A2
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
AUPQ912000A0
(en)
|
2000-07-31 |
2000-08-24 |
Crown In The Right Of The Queensland Department Of Health, The |
Improved virus like particles
|
|
WO2002053141A2
(en)
|
2000-12-14 |
2002-07-11 |
Coley Pharmaceutical Group, Inc. |
Inhibition of angiogenesis by nucleic acids
|
|
US7094409B2
(en)
|
2001-01-19 |
2006-08-22 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of allergic eosinophilic diseases
|
|
US7320793B2
(en)
|
2001-01-19 |
2008-01-22 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
US7128911B2
(en)
|
2001-01-19 |
2006-10-31 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of bone disease
|
|
US20030050268A1
(en)
|
2001-03-29 |
2003-03-13 |
Krieg Arthur M. |
Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
|
|
WO2003040308A2
(en)
|
2001-07-27 |
2003-05-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo
|
|
CA2492823A1
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
|
ES2321491T3
(es)
|
2001-10-05 |
2009-06-08 |
Cytos Biotechnology Ag |
Conjugados que llevan peptido angiotensina y uso de los mismos.
|
|
US7115266B2
(en)
|
2001-10-05 |
2006-10-03 |
Cytos Biotechnology Ag |
Angiotensin peptide-carrier conjugates and uses thereof
|
|
AU2002346960A1
(en)
|
2001-10-06 |
2003-04-22 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
|
ES2320638T3
(es)
|
2001-11-07 |
2009-05-27 |
Cytos Biotechnology Ag |
Disposicion ordenada de antigenos il-5, il-13 o eotasina, para el tratamiento de enfermedades alergicas con un componente eosinofilico.
|
|
BR0213941A
(pt)
|
2001-11-07 |
2004-08-31 |
Cytos Biotechnology Ag |
Arranjos de antìgeno para o tratamento de doença óssea
|
|
TW200303759A
(en)
|
2001-11-27 |
2003-09-16 |
Schering Corp |
Methods for treating cancer
|
|
US20030219459A1
(en)
|
2002-01-18 |
2003-11-27 |
Cytos Biotechnology Ag |
Prion protein carrier-conjugates
|
|
WO2003059386A2
(en)
|
2002-01-18 |
2003-07-24 |
Cytos Biotechnology Ag |
Prion protein carrier-conjugates
|
|
BR0311995A
(pt)
|
2002-06-20 |
2005-04-05 |
Cytos Biotechnology Ag |
Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
|
|
JP4726483B2
(ja)
|
2002-07-17 |
2011-07-20 |
サイトス バイオテクノロジー アーゲー |
分子抗原アレイ
|
|
MXPA04011247A
(es)
|
2002-07-19 |
2005-02-17 |
Cytos Biotechnology Ag |
Conjugados portadores de grelina.
|
|
WO2004071493A1
(en)
|
2003-02-17 |
2004-08-26 |
Peter Burkhard |
Peptidic nanoparticles as drug delivery and antigen display systems
|
|
US20060210588A1
(en)
*
|
2003-03-26 |
2006-09-21 |
Cytos Biotechnology Ag |
Hiv-peptide-carrier-conjugates
|
|
US7537767B2
(en)
*
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
|
RU2351362C2
(ru)
*
|
2003-03-26 |
2009-04-10 |
Цитос Байотекнолоджи Аг |
КОНЪЮГАТЫ ПЕПТИДА Melan-A, АНАЛОГА ВИРУСОПОДОБНОЙ ЧАСТИЦЫ
|
|
EP1644034B1
(en)
*
|
2003-07-10 |
2011-01-12 |
Cytos Biotechnology AG |
Composition for enhancing an immune response comprising packaged virus-like particles
|
|
CA2544240A1
(en)
|
2003-07-22 |
2005-02-17 |
Cytos Biotechnology Ag |
Cpg-packaged liposomes
|
|
CN101454451A
(zh)
|
2003-10-30 |
2009-06-10 |
科勒制药有限公司 |
具有增强免疫刺激能力的c类寡核苷酸类似物
|
|
NZ550110A
(en)
|
2004-04-14 |
2009-09-25 |
Genentech Inc |
Compositions and methods comprising an EGFL7 antagonist for modulating vascular development
|
|
JP2008501658A
(ja)
|
2004-06-02 |
2008-01-24 |
サイトス バイオテクノロジー アーゲー |
非ヒトｔｎｆ−ペプチドの担体コンジュゲートの医学上の使用
|
|
DE102004041340A1
(de)
|
2004-08-20 |
2006-02-23 |
Deutsche Gelatine-Fabriken Stoess Ag |
Nanopartikel und Verfahren zu deren Herstellung
|
|
MX2007003171A
(es)
*
|
2004-09-21 |
2007-05-23 |
Cytos Biotechnology Ag |
Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico.
|
|
PL1868642T3
(pl)
|
2005-03-18 |
2013-10-31 |
Cytos Biotechnology Ag |
Białka fuzyjne alergenów kocich i ich zastosowania
|
|
ATE515566T1
(de)
|
2005-05-26 |
2011-07-15 |
Cytos Biotechnology Ag |
Skalierbares fermentationsverfahren
|
|
US20110027220A1
(en)
|
2005-09-28 |
2011-02-03 |
Cytos Biotechnology Ag |
Interleukin-1 Conjugates and Uses Thereof
|
|
WO2007068747A1
(en)
*
|
2005-12-14 |
2007-06-21 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
JP5437797B2
(ja)
|
2006-06-12 |
2014-03-12 |
サイトス バイオテクノロジー アーゲー |
Ｒｎａバクテリオファージのウイルス様粒子にオリゴヌクレオチドをパッケージ化するための方法
|
|
JP5396809B2
(ja)
|
2008-10-17 |
2014-01-22 |
ソニー株式会社 |
固体撮像装置、カメラ、および、固体撮像装置の製造方法
|